The predictive and prognostic significance of pre- and post-treatment topoisomerase II alpha in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer | |
Chen, S.; Huang, L.; Liu, Y.; Chen, C. M.; Wu, J.; Shao, Z. M. | |
刊名 | EJSO |
2013 | |
卷号 | 39期号:6 |
关键词 | Breast cancer Neoadjuvant chemotherapy Human epidermal receptor-2 topoisomerase II alpha Anthracycline |
ISSN号 | 0748-7983 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4893124 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chen, S.,Huang, L.,Liu, Y.,et al. The predictive and prognostic significance of pre- and post-treatment topoisomerase II alpha in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer[J]. EJSO,2013,39(6). |
APA | Chen, S.,Huang, L.,Liu, Y.,Chen, C. M.,Wu, J.,&Shao, Z. M..(2013).The predictive and prognostic significance of pre- and post-treatment topoisomerase II alpha in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer.EJSO,39(6). |
MLA | Chen, S.,et al."The predictive and prognostic significance of pre- and post-treatment topoisomerase II alpha in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer".EJSO 39.6(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论